Picture of Kdventures AB logo

KDV B — Kdventures AB News Story

0.000.00%
se flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapSucker Stock

Brief: Karolinska Development Portfolio Co Publishes Data On Golexanolone

Sept 4 (Reuters) - Karolinska Development AB KDEV.ST:

KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY UMECRINE COGNITION PUBLISHES DATA SHOWING SUSTAINED EFFECT OF GOLEXANOLONE IN A PARKINSON'S DISEASE MODEL

Source text: ID:nGNE4Z0pBl

Further company coverage: KDEV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Kdventures AB

See all news